The finding demonstrated a substantial preventive effect of OSO-HDL to suppress CML-triggered hepatic IL-6, ROS production, and apoptotic cell death. The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.